logo

For the Inventor, By the Inventor

Lawrence, KS, United States of America

Paul Hanson

This inventor holds 7 USPTO granted patents. Top assignee: University of Kansas. Active years: 2002-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Hanson. Retrieved from https://idiyas.com/inventor/paul-hanson-p5mao8rs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 57.1

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:

goldMedal7 out of 573 
 
University of Kansas
 patents

Years Active: 2002-2018

Loading Chart...
7 patents (USPTO):Explore Patents
1. 10059722 - Cephalosporin derivatives and methods of use (2018-08-28),
2. 9556294 - Magnetic particle-polymer hybrid materials with functionalized polymers derived from norbornenyl reagents (2017-01-31),
3. 9035003 - High capacity magnetic nanoparticles as supports for reagents and catalysts (2015-05-19),
4. 9029457 - Silica-supported oligomeric hybrid materials (2015-05-12),
5. 6420592 - Amino acid-derived phosponamidic anhydrides and methods of preparing the same (2002-07-16),
6. 6420586 - Amino acid-derived cyclic phosphonamides and methods of synthesizing the same (2002-07-16),
7. 6359129 - Amino acid-derived, 7-membered cyclic sulfamides and methods of synthesizing the same (2002-03-19),

Title: Paul Hanson - Innovator in Medical Research

Introduction

Paul Hanson is a distinguished inventor based in Lawrence, Kansas. He has made significant contributions to the field of medical research, particularly in the development of innovative solutions for treating infectious diseases. With a total of 7 patents to his name, his work continues to impact the scientific community.

Latest Patents

Among his latest patents, Paul has developed cephalosporin derivatives and methods of use. This invention provides cephalosporin derivatives that are effective in killing or inhibiting the spread of microorganisms, particularly in the treatment of infectious diseases. Another notable patent involves magnetic particle-polymer hybrid materials with functionalized polymers derived from norbornenyl reagents. This invention describes a magnetic particle-polymer hybrid material that includes a magnetic particle smaller than 1 mm, linked to a functionalized polymer, which has applications in various fields.

Career Highlights

Paul Hanson is affiliated with the University of Kansas Medical Center Research Institute, where he conducts his research and development work. His innovative approach and dedication to advancing medical science have earned him recognition in his field.

Collaborations

Throughout his career, Paul has collaborated with esteemed colleagues, including Alan Rolfe and Oliver Reiser. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

In summary, Paul Hanson is a notable inventor whose work in medical research has led to significant advancements in the treatment of infectious diseases. His contributions continue to shape the future of medical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…